Cancer Biology & Medicine Open Access Editor-in-Chief: Xishan Hao
Keyword: biomarker
Original Article | Open Access
DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation
Published: 29 December 2023
2024, 21 (3): 252-266
Original Article | Open Access
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Published: 25 November 2021
2022, 19 (6): 910-930
Review | Open Access
Competing endogenous RNAs in lung cancer
Published: 01 February 2021
2021, 18 (1): 1-20
Original Article | Open Access
Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study
Published: 01 February 2021
2021, 18 (1): 256-270
Review | Open Access
Current research on circular RNAs and their potential clinical implications in breast cancer
Published: 01 August 2021
2021, 18 (3): 635-648
Original Article | Open Access
The mutational pattern of homologous recombination (HR)-associated genes and its relevance to the immunotherapeutic response in gastric cancer
Published: 15 November 2020
2020, 17 (4): 1002-1013
Original Article | Open Access
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
Published: 29 August 2022
2022, 19 (8): 1139-1149
Review | Open Access
MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy
Published: 15 August 2020
2020, 17 (3): 569-582
Original Article | Open Access
Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer
Published: 15 August 2020
2020, 17 (3): 652-663
Total 9